John W Childs - Net Worth and Insider Trading

John W Childs Net Worth

The estimated net worth of John W Childs is at least $276 Million dollars as of 2024-06-15. John W Childs is the Director of Biohaven Ltd and owns about 6,432,244 shares of Biohaven Ltd (BHVN) stock worth over $218 Million. John W Childs is the Director of Biohaven Pharmaceutical Holding Co Ltd and owns about 2,560,801 shares of Biohaven Pharmaceutical Holding Co Ltd (BHVN) stock worth over $36 Million. John W Childs is also the Director, 10% Owner of Mattress Firm Holding Corp and owns about 345,038 shares of Mattress Firm Holding Corp (MFRM) stock worth over $22 Million. Details can be seen in John W Childs's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that John W Childs has not made any transactions after 2024-05-30 and currently still holds the listed stock(s).

Transaction Summary of John W Childs

To

John W Childs Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, John W Childs owns 3 companies in total, including Biohaven Pharmaceutical Holding Co Ltd (BHVN) , Mattress Firm Holding Corp (MFRM) , and Biohaven Ltd (BHVN) .

Click here to see the complete history of John W Childs’s form 4 insider trades.

Insider Ownership Summary of John W Childs

Ticker Comapny Transaction Date Type of Owner
BHVN Biohaven Pharmaceutical Holding Co Ltd 2021-11-10 director & 10 percent owner
MFRM Mattress Firm Holding Corp 2016-09-14 director & 10 percent owner
BHVN Biohaven Ltd 2024-05-30 director

John W Childs Latest Holdings Summary

John W Childs currently owns a total of 3 stocks. Among these stocks, John W Childs owns 6,432,244 shares of Biohaven Ltd (BHVN) as of May 30, 2024, with a value of $218 Million and a weighting of 78.91%. John W Childs owns 2,560,801 shares of Biohaven Pharmaceutical Holding Co Ltd (BHVN) as of November 10, 2021, with a value of $36 Million and a weighting of 13.08%. John W Childs also owns 345,038 shares of Mattress Firm Holding Corp (MFRM) as of February 3, 2016, with a value of $22 Million and a weighting of 8.01%.

Latest Holdings of John W Childs

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
BHVN Biohaven Ltd 2024-05-30 6,432,244 33.83 217,602,815
BHVN Biohaven Pharmaceutical Holding Co Ltd 2021-11-10 2,560,801 14.08 36,056,078
MFRM Mattress Firm Holding Corp 2016-02-03 345,038 64.02 22,089,333

Holding Weightings of John W Childs


John W Childs Form 4 Trading Tracker

According to the SEC Form 4 filings, John W Childs has made a total of 8 transactions in Biohaven Ltd (BHVN) over the past 5 years, including 8 buys and 0 sells. The most-recent trade in Biohaven Ltd is the acquisition of 28,000 shares on May 30, 2024, which cost John W Childs around $996,240.

According to the SEC Form 4 filings, John W Childs has made a total of 9 transactions in Biohaven Pharmaceutical Holding Co Ltd (BHVN) over the past 5 years, including 8 buys and 1 sells. The most-recent trade in Biohaven Pharmaceutical Holding Co Ltd is the acquisition of 5,000 shares on November 10, 2021, which cost John W Childs around $614,350.

According to the SEC Form 4 filings, John W Childs has made a total of 0 transactions in Mattress Firm Holding Corp (MFRM) over the past 5 years. The most-recent trade in Mattress Firm Holding Corp is the acquisition of 559,440 shares on February 3, 2016, which cost John W Childs around $20 Million.

Insider Trading History of John W Childs

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

John W Childs Trading Performance

GuruFocus tracks the stock performance after each of John W Childs's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by John W Childs is 34.1%. GuruFocus also compares John W Childs's trading performance to market benchmark return within the same time period. The performance of stocks bought by John W Childs within 3 months outperforms 14 times out of 15 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how John W Childs's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of John W Childs

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
10 out of 10 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 9.15 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 6.26 LIMIT LIMIT LIMIT LIMIT LIMIT

John W Childs Ownership Network

Ownership Network List of John W Childs

No Data

Ownership Network Relation of John W Childs

Insider Network Chart

John W Childs Owned Company Details

What does Biohaven Pharmaceutical Holding Co Ltd do?

Who are the key executives at Biohaven Pharmaceutical Holding Co Ltd?

John W Childs is the director & 10 percent owner of Biohaven Pharmaceutical Holding Co Ltd. Other key executives at Biohaven Pharmaceutical Holding Co Ltd include VP & Chief Accounting Officer George C. Clark , Chief Medical Officer Elyse Stock , and Chief Financial Officer James Engelhart .

Biohaven Pharmaceutical Holding Co Ltd (BHVN) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Biohaven Pharmaceutical Holding Co Ltd (BHVN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Biohaven Pharmaceutical Holding Co Ltd (BHVN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Biohaven Pharmaceutical Holding Co Ltd (BHVN)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Biohaven Pharmaceutical Holding Co Ltd Insider Transactions

No Available Data

John W Childs Mailing Address

Above is the net worth, insider trading, and ownership report for John W Childs. You might contact John W Childs via mailing address: 111 Huntington Avenue, Suite 2900, Boston Ma 02199.

Discussions on John W Childs

No discussions yet.